Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

[Neck dissection of the residually positive neck after primary radiochemotherapy for locally advanced head and neck cancer].

Christiansen H, Rödel RM.

Strahlenther Onkol. 2012 May;188(5):444-5. doi: 10.1007/s00066-011-0064-1. German. No abstract available.

PMID:
22327867
2.

Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.

Frank DK, Hu KS, Culliney BE, Persky MS, Nussbaum M, Schantz SP, Malamud SC, Holliday RA, Khorsandi AS, Sessions RB, Harrison LB.

Laryngoscope. 2005 Jun;115(6):1015-20.

PMID:
15933512
3.

Neck dissection following radiochemotherapy of advanced head and neck cancer--for selected cases only?

Grabenbauer GG, Rödel C, Ernst-Stecken A, Brunner T, Hornung J, Kittel K, Steinhart H, Iro H, Sauer R, Schultze-Mosgau S.

Radiother Oncol. 2003 Jan;66(1):57-63.

PMID:
12559521
4.

Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.

Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1418-23.

PMID:
15050318
5.

Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer.

López Rodríguez M, Cerezo Padellano L, Martín Martín M, Couñago Lorenzo F.

Clin Transl Oncol. 2008 Dec;10(12):812-6.

PMID:
19068452
6.

Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group.

Vedrine PO, Thariat J, Hitier M, Janot F, Kaminsky MC, Makeieff M, De Raucourt D, Lapeyre M, Toussaint B; French Groupe d'Etude des Tumeurs de la Tête et du Cou Group.

Laryngoscope. 2008 Oct;118(10):1775-80. doi: 10.1097/MLG.0b013e31817f192a.

PMID:
18806474
7.

A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.

Fortin A, Caouette R, Wang CS, Vigneault E.

Am J Clin Oncol. 2008 Aug;31(4):379-83. doi: 10.1097/COC.0b013e318165c036.

PMID:
18845998
8.

Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.

Deron P, Mertens K, Goethals I, Rottey S, Duprez F, De Neve W, Vermeersch H, Van de Wiele C.

Nuklearmedizin. 2011;50(4):141-6. doi: 10.3413/Nukmed-0367-10-11. Epub 2011 May 19.

PMID:
21594304
9.

Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.

Lau H, Phan T, Mackinnon J, Matthews TW.

Arch Otolaryngol Head Neck Surg. 2008 Mar;134(3):257-61. doi: 10.1001/archoto.2007.49.

PMID:
18347249
10.

Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: how much is enough?

Sandhu A, Rao N, Giri S, He F, Karakla D, Wadsworth T, McGaughey D, Silverberg M.

Acta Oncol. 2008;47(5):948-53.

PMID:
17906982
11.
12.

Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.

Büntzel J, Glatzel M, Kuttner K, Weinaug R, Fröhlich D.

Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):4-13.

PMID:
11917277
13.

Treatment outcome in the residually positive neck after definitive chemotherapy and irradiation.

Dooley LM, Potts KL, Wilson LD, Cappello ZJ, Bumpous JM.

Laryngoscope. 2011 Aug;121(8):1656-61. doi: 10.1002/lary.21888. Epub 2011 May 27.

PMID:
21626511
14.

Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors.

Reichel O, Panzer M, Wimmer C, Dühmke E, Kastenbauer E, Suckfüll M.

Eur Arch Otorhinolaryngol. 2003 May;260(5):248-53. Epub 2002 Dec 4.

PMID:
12750913
15.

[The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer].

Hermann RM, Krech R, Hartlapp J, Esser E, Christoph B, Müller MK, Wagner W.

Strahlenther Onkol. 2001 Jun;177(6):277-82. German.

PMID:
11446315
16.

Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.

Nguyen NP, Vos P, Lee H, Borok TL, Karlsson U, Martinez T, Welsh J, Cohen D, Hamilton R, Nguyen N, Nguyen LM, Vinh-Hung V.

Oncology. 2008;75(3-4):186-91. doi: 10.1159/000163058. Epub 2008 Oct 8.

PMID:
18841033
17.

Planned postradiotherapy neck dissection in patients with advanced head and neck cancer.

Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ.

Head Neck. 1998 Mar;20(2):132-7.

PMID:
9484944
18.

Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer.

Rudat V, Wannenmacher M.

Semin Surg Oncol. 2001 Jan-Feb;20(1):66-74. Review.

PMID:
11291134
19.

Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer.

Stadler P, Feldmann HJ, Creighton C, Kau R, Molls M.

Radiother Oncol. 1998 Aug;48(2):157-64.

PMID:
9783887
20.

Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.

Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, Sullivan CA, Li Y, Haddad RI.

Arch Otolaryngol Head Neck Surg. 2006 May;132(5):526-31.

PMID:
16702569

Supplemental Content

Support Center